Review article: emulsifiers in the food supply and implications for gastrointestinal disease
ConclusionsThere is limited evidence to directly link emulsifiers and thickeners to human disease, but multiple potential pathogenic mechanisms. Knowledge of actual dietary intake and high ‐quality interventional studies is needed to enable the risks associated with their intake to be understood. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - November 28, 2018 Category: Drugs & Pharmacology Authors: Emma P. Halmos, Alexandra Mack, Peter R. Gibson Tags: REVIEW ARTICLE Source Type: research

Sustained virologic response rates in patients with chronic hepatitis C genotype 6 treated with ledipasvir+sofosbuvir or sofosbuvir+velpatasvir
SummaryBackgroundHepatitis C virus (HCV) genotype 6 (GT 6) is the predominant genotype among certain Asian populations. The availability of newer DAA options is limited in many parts of Asia.AimTo compare sustained virologic response (SVR ‐12) rates between ledipasvir and sofosbuvir (LDV+SOF) and velpatasvir+SOF (SOF+VEL) for patients with HCVGT6 infection.MethodRetrospective study of consecutive adult HCVGT6 patients identified via ICD 9 code: 070.5 from United States treatment centers. Treatment was LDV+SOF or SOF+VEL for 8 ‐24 weeks. A 1:1 propensity score matching (PSM) on HCV RNA, cirrhosis, alanine aminotran...
Source: Alimentary Pharmacology and Therapeutics - November 22, 2018 Category: Drugs & Pharmacology Authors: Emily Nguyen, Sam Trinh, Huy Trinh, Huy Nguyen, Khanh Nguyen, Aivien Do, Brian Levitt, Son Do, My Nguyen, Treta Purohit, Eugenie Shieh, Mindie H. Nguyen Tags: ORIGINAL ARTICLE Source Type: research

Review article: the pharmacological causes of colon ischaemia
ConclusionsPatients presenting with abdominal pain, diarrhoea, or bloody stool need to be evaluated for the possibility of this condition and treated accordingly. Timely diagnosis is necessary to improve patient outcomes. This review aims to increase awareness among clinicians regarding the presentation of pharmacologically induced colonic ischaemia. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - November 22, 2018 Category: Drugs & Pharmacology Authors: Ziga Vodusek, Paul Feuerstadt, Lawrence J. Brandt Tags: REVIEW ARTICLE Source Type: research

Combining hepatitis B core ‐related and surface antigens at end of nucleos(t)ide analogue treatment to predict off‐therapy relapse risk
ConclusionsSerum HBcrAg and HBsAg levels were independent predictors of off ‐NA relapse and can be factored into a risk score to guide treatment cessation in patients with CHB. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - November 19, 2018 Category: Drugs & Pharmacology Authors: Yao ‐Chun Hsu, Mindie H. Nguyen, Lein‐Ray Mo, Ming‐Shiang Wu, Tzeng‐Huey Yang, Chieh‐Chang Chen, Cheng‐Hao Tseng, Chi‐Ming Tai, Chun‐Ying Wu, Jaw‐Town Lin, Yasuhito Tanaka, Chi‐Yang Chang Tags: ORIGINAL ARTICLE Source Type: research

Response to treatment is more important than disease severity at diagnosis for prediction of early relapse in new ‐onset paediatric Crohn’s disease
ConclusionsEarly relapses were associated with a higher risk for disease complications at followup. Relapse prediction based on week 12 disease activity or inflammation is superior to prediction using data from diagnosis. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - November 18, 2018 Category: Drugs & Pharmacology Authors: Tomer Ziv ‐Baran, Séamus Hussey, Malgorzata Sladek, Jorge Amil Dias, Javier Martin de Carpi, Erasmo Miele, Gabor Veres, Paolo Lionetti, Sibylle Koletzko, Federica Nuti, Anders Paerregaard, Kaija‐Leena Kolho, Richard K. Russell, Ron Shaou Tags: ORIGINAL ARTICLE Source Type: research

Systematic review and meta ‐analysis: portal vein recanalisation and transjugular intrahepatic portosystemic shunt for portal vein thrombosis
SummaryBackgroundTransjugular intrahepatic portosystemic shunt has been increasingly used in patients with portal vein thrombosis to obtain patency, but evidenced ‐based decisions are challenging.AimTo evaluate published data on efficacy and safety of endovascular therapy in portal vein thrombosis.MethodsSystematic search of PubMed, ISI, Scopus, and Embase for studies (in English, until October 2017) reporting feasibility, safety, 12 ‐month portal vein recanalisation, transjugular intrahepatic portosystemic shunt patency, and survival in patients with benign portal vein thrombosis undergoing endovascular treatment. An ...
Source: Alimentary Pharmacology and Therapeutics - November 18, 2018 Category: Drugs & Pharmacology Authors: Susana G. Rodrigues, Sebastian Sixt, Juan G. Abraldes, Andrea De Gottardi, Christoph Klinger, Jaime Bosch, Iris Baumgartner, Annalisa Berzigotti Tags: SYSTEMATIC REVIEW WITH META ‐ANALYSIS Source Type: research

Ascitic cholesterol is superior to serum ‐ascites albumin gradient in the detection of non‐portal hypertensive ascites and the diagnosis of mixed ascites
ConclusionAscitic cholesterol is an excellent measure for detecting NPH ascites and for identifying peritoneal lesions in mixed ascites. Thus, this simple and cost ‐effective measure should be determined in patients with new‐onset ascites (www.chictr.org.cn; ChiCTR ‐DCD‐15006907). (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - November 15, 2018 Category: Drugs & Pharmacology Authors: Li Du, Shenghua Zhu, Zhiwen Lu, Ting Xu, Tao Bai, Dong Xu, Xiuqi Wei, Jin Li, Keshu Xu, Jin Ye, Xiaohua Hou, Yuhu Song Tags: ORIGINAL ARTICLE Source Type: research

Incidence and predictors of new persistent opioid use following inflammatory bowel disease flares treated with oral corticosteroids
ConclusionsNew persistent opioid use is common in IBD patients who experience a flare, especially among those with mental health disorders, COPD, and Crohn's disease or indeterminate colitis. These findings can be helpful in risk ‐stratifying patients when choosing an acute pain therapy and providing counselling before choosing to prescribe opioids to opioid‐naïve patients experiencing an IBD flare. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - November 14, 2018 Category: Drugs & Pharmacology Authors: Mohamed Noureldin, Peter D. R. Higgins, Shail M. Govani, Shirley Cohen ‐Mekelburg, Brooke C. Kenney, Ryan W. Stidham, Jennifer F. Waljee, Akbar K. Waljee Tags: ORIGINAL ARTICLE Source Type: research

Randomised clinical trial: emricasan versus placebo significantly decreases ALT and caspase activation in subjects with non ‐alcoholic fatty liver disease
SummaryBackgroundLipotoxicity leading to excessive caspase ‐mediated apoptosis and inflammation is believed to drive liver damage in NAFLD. Emricasan is a pan‐caspase inhibitor that decreased serum ALT and apoptotic and inflammatory markers in subjects with chronic hepatitis.AimsTo assess whether 28  days of emricasan would reduce elevated levels of serum ALT, AST, cleaved cytokeratin‐18, full‐length cytokeratin‐18, and caspase 3/7 in subjects with NAFLD and raised aminotransferases.MethodsDouble ‐blind, placebo‐controlled, office‐practice study assessed the efficacy, safety, and tolerability of emrica...
Source: Alimentary Pharmacology and Therapeutics - November 14, 2018 Category: Drugs & Pharmacology Authors: Mitchell Shiffman, Bradley Freilich, Raj Vuppalanchi, Kymberly Watt, Jean L. Chan, Al Spada, David T. Hagerty, Eugene Schiff Tags: RANDOMISED CLINICAL TRIAL Source Type: research

Loss of paraspinal muscle mass is a gender ‐specific consequence of cirrhosis that predicts complications and death
ConclusionsThis study links muscle wasting in patients with cirrhosis predominantly to males. However, the presence of a low PSMI mass is a gender ‐independent predictor of developing cirrhosis‐associated complications and death. Scores combining the MELD with muscle parameters should be re‐validated by utilizing the PSMI. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - November 11, 2018 Category: Drugs & Pharmacology Authors: Cornelius Engelmann, Stefan Schob, Ines Nonnenmacher, Luise Werlich, Niklas Aehling, Sebastian Ullrich, Thorsten Kaiser, Sandra Krohn, Adam Herber, Robert Sucher, Michael Bartels, Alexey Surov, Dirk Hasenclever, Thomas Kahn, Daniel Seehofer, Tags: ORIGINAL ARTICLE Source Type: research

Systematic review and meta ‐analysis: defecography should be a first‐line diagnostic modality in patients with refractory constipation
ConclusionsPathological structural abnormalities, as well as functional abnormalities, are common in patients with chronic constipation. Since structural abnormalities cannot be evaluated using nonimaging test modalities (balloon expulsion and anorectal manometry), defecography should be considered the first ‐line diagnostic test if resources allow. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - November 11, 2018 Category: Drugs & Pharmacology Authors: Ugo Grossi, Gian Luca Di Tanna, Henriette Heinrich, Stuart A. Taylor, Charles H. Knowles, S. Mark Scott Tags: SYSTEMATIC REVIEW WITH META ‐ANALYSIS Source Type: research

Loss of tolerance to glycoprotein 2 isoforms 1 and 4 is associated with Crohn ’s disease of the pouch
SummaryBackgroundZymogen granule glycoprotein 2 (GP2) is a major autoantigen of Crohn's disease ‐specific pancreatic autoantibodies.AimTo test a link between loss of tolerance to isoforms of GP2 and pouch disorders in a cross ‐sectional study in ulcerative colitis patients with ileal pouch‐anal anastomosis (IPAA).MethodsSerum samples of 117 consecutive ulcerative colitis patients after IPAA were tested for presence of Anti ‐GP2 isoforms 1 (GP21)& 4 (GP24) IgG and IgA as well as anti ‐Saccaromyces cervisiae (ASCA) IgG and IgA antibodies in a blinded fashion via enzyme ‐linked immunosorbent assay. Pouch disor...
Source: Alimentary Pharmacology and Therapeutics - November 8, 2018 Category: Drugs & Pharmacology Authors: Donelle Cummings, Michael Cruise, Rocio Lopez, Dirk Roggenbuck, Vipul Jairath, Yinghong Wang, Bo Shen, Florian Rieder Tags: ORIGINAL ARTICLE Source Type: research

Systematic review: efficacy and safety of switching patients between reference and biosimilar infliximab
ConclusionsWhile available data have not identified significant risks associated with a single switch between reference and biosimilar infliximab, the studies available currently report on only single switches and were mostly observational studies lacking control arms. Additional data are needed to explore potential switching risks in various populations and scenarios. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - November 8, 2018 Category: Drugs & Pharmacology Authors: Brian G. Feagan, Gordon Lam, Christopher Ma, Gary R. Lichtenstein Tags: SYSTEMATIC REVIEW Source Type: research

Systematic review: the consequences of psychosocial effects of inflammatory bowel disease on patients ′ reproductive health
ConclusionThis review recommends pre ‐conception counselling for all IBD patients of childbearing age to tackle poor knowledge and allow patients to make an informed decision on their reproductive health. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - November 8, 2018 Category: Drugs & Pharmacology Authors: Satvinder Purewal, Sarah Chapman, Wladyslawa Czuber ‐Dochan, Christian Selinger, Helen Steed, Matthew J. Brookes Tags: SYSTEMATIC REVIEW Source Type: research

Systematic review: predictive biomarkers of therapeutic response in inflammatory bowel disease —Personalised medicine in its infancy
Alimentary Pharmacology&Therapeutics, EarlyView. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - October 31, 2018 Category: Drugs & Pharmacology Authors: Toer W. Stevens, Mijntje Matheeuwsen, Maria H. L önnkvist, Claire E. Parker, Manon E. Wildenberg, Krisztina B. Gecse, Geert R. D’Haens Source Type: research

Systematic review with network meta ‐analysis: the impact of medical interventions for moderate‐to‐severe ulcerative colitis on health‐related quality of life
Alimentary Pharmacology&Therapeutics, EarlyView. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - October 31, 2018 Category: Drugs & Pharmacology Authors: Paschalis Paschos, Anastasia Katsoula, Georgia Salanti, Olga Giouleme, Eleni Athanasiadou, Apostolos Tsapas Source Type: research

Issue Information
Alimentary Pharmacology&Therapeutics,Volume 48, Issue 10, Page 1041-1043, November 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - October 30, 2018 Category: Drugs & Pharmacology Source Type: research

Editorial: which inflammatory bowel disease patients should be screened for Epstein ‐Barr virus infection?
Alimentary Pharmacology&Therapeutics,Volume 48, Issue 10, Page 1158-1159, November 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - October 30, 2018 Category: Drugs & Pharmacology Authors: Amneet K. Hans, Frank I. Scott Source Type: research

Editorial: predicting recurrence of Crohn's disease after surgical resection —Close to a crystal ball. Authors’ reply
Alimentary Pharmacology&Therapeutics,Volume 48, Issue 10, Page 1157-1158, November 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - October 30, 2018 Category: Drugs & Pharmacology Authors: Matthieu Allez, Claire Auzolle, Lionel Le Bourhis, Philippe Seksik Source Type: research

Editorial: hepatitis B, fatty liver, and metabolic syndrome —interaction or co‐existence?
Alimentary Pharmacology&Therapeutics,Volume 48, Issue 10, Page 1160-1161, November 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - October 30, 2018 Category: Drugs & Pharmacology Authors: Rajneesh Kumar, Chee ‐Kiat Tan Source Type: research

Editorial: hepatitis B, fatty liver and metabolic syndrome —Interaction or co‐existence? Authors’ reply
Alimentary Pharmacology&Therapeutics,Volume 48, Issue 10, Page 1162-1163, November 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - October 30, 2018 Category: Drugs & Pharmacology Authors: Yuan ‐Hung Kuo, Sheng‐Nan Lu Source Type: research

Editorial: which inflammatory bowel disease patients should be screened for Epstein ‐Barr virus infection? Authors’ reply
Alimentary Pharmacology&Therapeutics,Volume 48, Issue 10, Page 1159-1160, November 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - October 30, 2018 Category: Drugs & Pharmacology Authors: Ruth Francisco, Andr és Castaño‐García, Sabino Riestra Source Type: research

Editorial: predicting recurrence of Crohn's disease after surgical resection —close to a crystal ball
Alimentary Pharmacology&Therapeutics,Volume 48, Issue 10, Page 1156-1157, November 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - October 30, 2018 Category: Drugs & Pharmacology Authors: Siddharth Singh Source Type: research

Letter: effect of HCV eradication on cardiovascular disease —Authors’ reply
Alimentary Pharmacology&Therapeutics,Volume 48, Issue 10, Page 1169-1170, November 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - October 30, 2018 Category: Drugs & Pharmacology Authors: Anna Licata, Maurizio Soresi, Giuseppina Novo Source Type: research

Letter: association between proton pump inhibitors and the risk of hepatocellular carcinoma —authors’ reply
Alimentary Pharmacology&Therapeutics,Volume 48, Issue 10, Page 1165-1166, November 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - October 30, 2018 Category: Drugs & Pharmacology Authors: Yu ‐Hsuan Joni Shao, Szu‐Yuan Wu Source Type: research

Letter: gluten sensitivity in patients with inflammatory bowel disease
Alimentary Pharmacology&Therapeutics,Volume 48, Issue 10, Page 1167-1168, November 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - October 30, 2018 Category: Drugs & Pharmacology Authors: Michael D. Potter, Marjorie M. Walker, Michael P. Jones, Natasha A. Koloski, Simon Keely, Nicholas J. Talley Source Type: research

Letter: effects of HCV eradication on cardiovascular diseases
Alimentary Pharmacology&Therapeutics,Volume 48, Issue 10, Page 1168-1169, November 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - October 30, 2018 Category: Drugs & Pharmacology Authors: Zhiqing He, Ru Ding, Haiguang Xin, Chun Liang Source Type: research

Letter: proton pump inhibitors and the risk of hepatocellular carcinoma
Alimentary Pharmacology&Therapeutics,Volume 48, Issue 10, Page 1164-1165, November 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - October 30, 2018 Category: Drugs & Pharmacology Authors: Antonio Ponzetto, Natale Figura Source Type: research

Letter: faecal calprotectin, clinical indices and the diagnosis of inflammatory bowel disease
Alimentary Pharmacology&Therapeutics,Volume 48, Issue 10, Page 1166-1166, November 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - October 30, 2018 Category: Drugs & Pharmacology Authors: Eman Al Sulais, Turki AlAmeel Source Type: research

Clinical relevance of serum non ‐organ‐specific antibodies in patients with HCV infection receiving direct‐acting antiviral therapy
Alimentary Pharmacology&Therapeutics,Volume 48, Issue 10, Page 1138-1145, November 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - October 30, 2018 Category: Drugs & Pharmacology Authors: Endrit Shahini, Andrea Iannone, Domenico Romagno, Angelo Armandi, Sonia Carparelli, Mariabeatrice Principi, Maria Teresa Viggiani, Enzo Ierardi, Alfredo Di Leo, Michele Barone Source Type: research

Adults with eosinophilic oesophagitis identify symptoms and quality of life as the most important outcomes
Alimentary Pharmacology&Therapeutics,Volume 48, Issue 10, Page 1082-1090, November 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - October 30, 2018 Category: Drugs & Pharmacology Authors: Ekaterina Safroneeva, Lukas Balsiger, David Hafner, Claudia E. Kuehni, Marcel Zwahlen, Sven Trelle, S ébastien Godat, Luc Biedermann, Thomas Greuter, Stephan Vavricka, Alex Straumann, Alain M. Schoepfer Source Type: research

Longitudinal trends in renal function in chronic hepatitis B patients receiving oral antiviral treatment
Alimentary Pharmacology&Therapeutics, EarlyView. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - October 29, 2018 Category: Drugs & Pharmacology Authors: Prowpanga Udompap, Donghee Kim, Aijaz Ahmed, W. Ray Kim Source Type: research

Comorbidities, concomitant medications and potential drug ‐drug interactions with interferon‐free direct‐acting antiviral agents in hepatitis C patients in Taiwan
Alimentary Pharmacology&Therapeutics, EarlyView. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - October 26, 2018 Category: Drugs & Pharmacology Authors: Chen ‐Hua Liu, Ming‐Lung Yu, Cheng‐Yuan Peng, Tsai‐Yuan Hsieh, Yi‐Hsiang Huang, Wei‐Wen Su, Pin‐Nan Cheng, Chih‐Lin Lin, Ching‐Chu Lo, Chi‐Yi Chen, Jyh‐Jou Chen, Qian Ma, Craig Brooks‐Rooney, Jia‐Horng Kao Source Type: research

The effects of metabolic status on non ‐alcoholic fatty liver disease‐related outcomes, beyond the presence of obesity
Alimentary Pharmacology&Therapeutics, EarlyView. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - October 24, 2018 Category: Drugs & Pharmacology Authors: Javier Ampuero, Roc ío Aller, Rocío Gallego‐Durán, Jesus M. Banales, Javier Crespo, Carmelo García‐Monzón, María Jesús Pareja, Eduardo Vilar‐Gómez, Juan Caballería, Desamparados Escudero‐García, Judith Gomez‐Camarero, José Source Type: research

Influence of hepatitis C virus eradication with direct ‐acting antivirals on the gut microbiota in patients with cirrhosis
Alimentary Pharmacology&Therapeutics, EarlyView. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - October 22, 2018 Category: Drugs & Pharmacology Authors: Francesca Romana Ponziani, Lorenza Putignani, Francesco Paroni Sterbini, Valentina Petito, Anna Picca, Federica Del Chierico, Sofia Reddel, Riccardo Calvani, Emanuele Marzetti, Maurizio Sanguinetti, Antonio Gasbarrini, Maurizio Pompili Source Type: research

Persistent damage on magnetic resonance enterography in patients with Crohn ’s disease in endoscopic remission
Alimentary Pharmacology&Therapeutics, EarlyView. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - October 22, 2018 Category: Drugs & Pharmacology Authors: Jordi Rimola, Ignacio Alfaro, Agn ès Fernández‐Clotet, Jesús Castro‐Poceiro, Daniel Vas, Sonia Rodríguez, Maria Carme Masamunt, Ingrid Ordás, Elena Ricart, Julián Panés Source Type: research

Long ‐term prognostic value of the FibroTest in patients with non‐alcoholic fatty liver disease, compared to chronic hepatitis C, B, and alcoholic liver disease
Alimentary Pharmacology&Therapeutics, EarlyView. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - October 18, 2018 Category: Drugs & Pharmacology Authors: Mona Munteanu, Raluca Pais, Valentina Peta, Olivier Deckmyn, Joseph Moussalli, Yen Ngo, Marika Rudler, Pascal Lebray, Frederic Charlotte, Vincent Thibault, Olivier Lucidarme, An Ngo, Fran çoise Imbert‐Bismut, Chantal Housset, Dominique Th Source Type: research

Retraction: Randomised clinical trial: The clinical efficacy and safety of an alginate ‐antacid (Gaviscon Double Action) versus placebo, for decreasing upper gastrointestinal symptoms in symptomatic gastroesophageal reflux disease (GERD) in China by J. Sun, C. Yang, H. Zhao, P. Zheng, J. Wilkinson, B. Ng, Y. Yuan. Aliment Pharmacol Ther. 2015;42:845‐854.
Alimentary Pharmacology&Therapeutics,Volume 48, Issue 9, Page 1039-1039, November 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - October 15, 2018 Category: Drugs & Pharmacology Source Type: research

Issue Information
Alimentary Pharmacology&Therapeutics,Volume 48, Issue 9, Page 889-891, November 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - October 15, 2018 Category: Drugs & Pharmacology Source Type: research

Editorial: predicting hepatic encephalopathy after TIPSS —is multimodal cerebral MRI the answer?
Alimentary Pharmacology&Therapeutics,Volume 48, Issue 9, Page 1019-1020, November 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - October 15, 2018 Category: Drugs & Pharmacology Authors: Matthew J. Armstrong, Dhiraj Tripathi Source Type: research

Editorial: severe outcomes are rare in pregnancy with autoimmune hepatitis
Alimentary Pharmacology&Therapeutics,Volume 48, Issue 9, Page 1017-1018, November 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - October 15, 2018 Category: Drugs & Pharmacology Authors: Hannes Hagstrom, Jonas F. Ludvigsson Source Type: research

Editorial: hepatocellular carcinoma in non ‐cirrhotic NASH—a troubling reality
Alimentary Pharmacology&Therapeutics,Volume 48, Issue 9, Page 1021-1023, November 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - October 15, 2018 Category: Drugs & Pharmacology Authors: Marie Boyle, Quentin M. Anstee Source Type: research

Editorial: predicting hepatic encephalopathy after TIPSS —is multimodal cerebral MRI the answer? Authors’ reply
Alimentary Pharmacology&Therapeutics,Volume 48, Issue 9, Page 1020-1021, November 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - October 15, 2018 Category: Drugs & Pharmacology Authors: Marika Rudler, Damien Galanaud, Dominique Thabut Source Type: research

Editorial: severe outcomes are rare in pregnancy in autoimmune hepatitis —Authors' reply
Alimentary Pharmacology&Therapeutics,Volume 48, Issue 9, Page 1018-1019, November 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - October 15, 2018 Category: Drugs & Pharmacology Authors: Lisbet Gr ønbæk, Hendrik Vilstrup, Peter Jepsen Source Type: research

Letter: microwave vs radiofrequency ablation for hepatocellular carcinoma within the Milan criteria
Alimentary Pharmacology&Therapeutics,Volume 48, Issue 9, Page 1026-1026, November 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - October 15, 2018 Category: Drugs & Pharmacology Authors: Yao ‐Ming Zhang, Zhen‐Tao Zhou, Gao‐Min Liu Source Type: research

Letter: long ‐term treatment of severe bile acid diarrhoea—obeticholic acid can normalise SeHCAT retention
Alimentary Pharmacology&Therapeutics,Volume 48, Issue 9, Page 1032-1034, November 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - October 15, 2018 Category: Drugs & Pharmacology Authors: Julian R. F. Walters Source Type: research

Letter: acute liver failure of indeterminate aetiology
Alimentary Pharmacology&Therapeutics,Volume 48, Issue 9, Page 1024-1025, November 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - October 15, 2018 Category: Drugs & Pharmacology Authors: Keiichi Fujiwara, Shin Yasui, Osamu Yokosuka, Naoya Kato Source Type: research

Letter: which risk factors for post ‐operative recurrence in Crohn's disease can be modified?
Alimentary Pharmacology&Therapeutics,Volume 48, Issue 9, Page 1031-1032, November 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - October 15, 2018 Category: Drugs & Pharmacology Authors: Nicola Imperatore, Antonio Rispo, Gaetano Luglio, Luigi Bucci, Fabiana Castiglione Source Type: research

Letter: can a specific surgical approach reduce post ‐operative recurrence in Crohn's disease?
Alimentary Pharmacology&Therapeutics,Volume 48, Issue 9, Page 1030-1031, November 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - October 15, 2018 Category: Drugs & Pharmacology Authors: Takayuki Yamamoto, Paulo Gustavo Kotze Source Type: research

Letter: microwave vs radiofrequency ablation for hepatocellular carcinoma within the Milan criteria —Authors’ reply
Alimentary Pharmacology&Therapeutics,Volume 48, Issue 9, Page 1027-1028, November 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - October 15, 2018 Category: Drugs & Pharmacology Authors: Wenwu Liu, Binkui Li, Yunfei Yuan Source Type: research